SI-BONE announces Posteromedial Trajectory

Spinal Tech

SI-BONE (NASDAQ: SIBN) has introduced an advanced posteromedial technique for its iFuse TORQ® Implant System, expanding its suite of minimally invasive solutions for treating sacroiliac joint (SIJ) dysfunction. Developed in partnership with Dr. Babajide Ogunseinde from Longview, Texas, the posteromedial technique offers a streamlined approach to treating SIJ dysfunction that enables surgeons to address both SI joints through a single midline incision, with one surgical position. This innovation aims to improve efficiency in the operating room by simplifying the procedure for spine surgeons and interventional spine specialists.

Dr. Ogunseinde noted, “Developed with SI-BONE in Longview, Texas, the posteromedial technique is designed to transform the treatment of SI joint dysfunction. Its simplicity enables physicians to treat patients using a minimally invasive approach, enhancing both accessibility and efficiency in the OR.”

About SI-BONE, Inc. SI-BONE (NASDAQ: SIBN) is a leading provider of technology for the surgical treatment of sacropelvic disorders. Since 2009, SI-BONE has been at the forefront of minimally invasive SI joint surgery, supporting over 3,900 physicians in performing more than 100,000 sacropelvic procedures worldwide. SI-BONE’s technologies are backed by robust clinical evidence, including two randomized controlled trials and over 135 peerreviewed studies. Building on its expertise in minimally invasive SI joint fusion, SI-BONE has expanded into adjacent areas such as adult deformity, spinopelvic fixation, and pelvic trauma. For more information, visit www.si-bone.com.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers